162 results
Page 5 of 9
20-F/A
EX-4.38
d2orptm9eo
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
vuv7jzz mnw
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
gj1ewa2b59n1c8iyr
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
4jjfaza
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
ur7 izwdj
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
1iwsgwr e8hhyeuummj
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
pmwe9396qj x4
9 Feb 15
2015 Annual General Meeting of Shareholders
12:00am
424B2
iuv23m
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1.1
4q2 z3fef
30 May 14
Current report (foreign)
12:00am
F-3
z843gx fbr
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.2
j9ulejnyi
30 May 14
Current report (foreign)
12:00am
6-K
EX-1.1
zwyigvoj2 7upy
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
kmxvpxz6k2ms
4 Mar 14
Prospectus supplement for primary offering
12:00am